Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Other Accumulated Expenses (2023 - 2025)

INVO Fertility has reported Other Accumulated Expenses over the past 3 years, most recently at $10500.0 for Q3 2025.

  • Quarterly Other Accumulated Expenses fell 97.0% to $10500.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $10500.0 through Sep 2025, down 97.0% year-over-year, with the annual reading at $410000.0 for FY2024, 17.14% up from the prior year.
  • Other Accumulated Expenses was $10500.0 for Q3 2025 at INVO Fertility, roughly flat from $10500.0 in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $715245.0 in Q1 2025 and troughed at $10500.0 in Q2 2025.
  • The 3-year median for Other Accumulated Expenses is $350000.0 (2023), against an average of $296630.8.
  • Year-over-year, Other Accumulated Expenses surged 183.56% in 2024 and then plummeted 97.0% in 2025.
  • A 3-year view of Other Accumulated Expenses shows it stood at $350000.0 in 2023, then increased by 17.14% to $410000.0 in 2024, then tumbled by 97.44% to $10500.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Other Accumulated Expenses are $10500.0 (Q3 2025), $10500.0 (Q2 2025), and $715245.0 (Q1 2025).